Market News AIOpen the app

Wells Fargo Upgrades Zimmer Biomet to Overweight

OpinionRead the original at marketscreener.com
Good for ZBH

Wells Fargo upgraded Zimmer Biomet and raised its target from $113 to $123, a favorable signal. The report gives no new sales or profit results, so this is an analyst view, not proof of business improvement.

ZBH · Zimmer Biomet Holdings, Inc.

AI read · Good for ZBH

The AI's read

A more positive view from Wells Fargo may encourage confidence in Zimmer Biomet. The story reports no new sales, profit, or product changes, so this signal comes from the analyst's opinion rather than new company results.

Get alerts for ZBH

Follow Zimmer Biomet Holdings, Inc. (ZBH) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for ZBH
Free on the App Store and Google Play, or on the web.